Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
…term consequences and significant risk of longer-term morbidity.Tocilizumab is a humanized monoclonal antibody against the IL-6 receptor, u…
…ABI), patients are often commenced on anti-seizure medications (ASM). There are risks associated with indefinite ASM use but no evi…
…nts continued well beyond the 6 months reported here.Conclusion Cannabidiol demonstrates good efficacy and tolerability with high retention…
…Sarcoidosis and inclusion body myositis are idiopathic inflammatory diseases which are rarely reported …
…f risk stratification for patients with diabetes, hypertension, cardiovascular disease, and/or CKD.34 It is also recommended for patients with obesity…
…ed. Disease activity was assessed using the partial Mayo Score (ulcerative colitis) or Harvey-Bradshaw Index (Crohn’s disease). Logistic regressio…
… cardiac monitoring early in survivorship, especially in breast cancer survivors.…
…solid cancer treated with ICIs compared with those treated with chemotherapy, placebo or no treatment. Risk of bias was evaluated with the C…
…rces for feasible analysis.Conclusion Clinical actionability of I1307K should prioritise risk stratification based on overall CRC risk…
…t CA is an independent risk factor for AROs among patients with crush injury in South Africa. Victims of CA with renal dysfunction require a…
…Background Patients with Interstitial Lung Disease (ILD) have poorer access to specialist end of life care, experi…
…Background Choroidal melanoma can arise from malignant transformation of choroidal nevus. The…